Login Register Cart 0
Generic placeholder image

Protein & Peptide Letters

Editor-in-Chief

ISSN (Print): 0929-8665
ISSN (Online): 1875-5305

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Circ_0008768 Suppresses the Pancreatic Cancer Progression via miR-330- 3p/PTEN Axis

Author(s): Yingkai Wang, Jijun Zhang*, Jiepeng Jia, Bo Qian and Xiaowen Tian

Volume 29, Issue 9, 2022

Published on: 08 September, 2022

Page: [796 - 805] Pages: 10

DOI: 10.2174/0929866529666220726144619

Price: $65

Abstract

Objective: To probe the role of circular RNA_0008768 (circ_0008768) in the development of pancreatic cancer (PC) and its regulatory mechanism.

Methods: The expression levels of circ_0008768, miR-330-3p, and PTEN mRNA in PC tissues and cells were detected using qRT-PCR. Cell proliferation, migration and invasion of PC cells were detected by CCK-8 method, EdU method, and Transwell assay. The targeting relationship between circ_0008768 and miR-330-3p, as well as miR-330-3p and PTEN mRNA 3'UTR was analyzed by the dual-luciferase reporter assay. PTEN expression levels in PC cells were analyzed by Western blot.

Results: The expression levels of circ_0008768 and PTEN mRNA were significantly reduced in both PC tissues and cell lines. Overexpression of circ_0008768 exerted an inhibitory effect on the proliferation, migration and invasion of PC cells. Knocking down circ_0008768 showed the opposite effect. Circ_0008768 directly targeted and negatively regulated the expression of miR-330- 3p. PTEN was identified as a downstream target gene of miR-330-3p. Circ_0008768 could positively regulate the expression of PTEN.

Conclusion: In PC, circ_0008768 can act as a tumor-suppressive factor to inhibit the development of PC by regulating the miR-330-3p/PTEN molecular axis.

Keywords: Pancreatic cancer, circ_0008768, miR-330-3p, PTEN, cell proliferation, overexpression.

« Previous Next »
[1]
Ilic, M.; Ilic, I. Epidemiology of pancreatic cancer. World J. Gastroenterol., 2016, 22(44), 9694-9705.
[http://dx.doi.org/10.3748/wjg.v22.i44.9694] [PMID: 27956793]
[2]
Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2018, 68(6), 394-424.
[http://dx.doi.org/10.3322/caac.21492] [PMID: 30207593]
[3]
Dreyer, S.B.; Chang, D.K.; Bailey, P.; Biankin, A.V. Pancreatic cancer genomes: Implications for clinical management and therapeutic development. Clin. Cancer Res., 2017, 23(7), 1638-1646.
[http://dx.doi.org/10.1158/1078-0432.CCR-16-2411] [PMID: 28373362]
[4]
Kichi, Z.A.; Rezaei, Z.; Soltani, M.; Farsani, Z.S. Molecular epidemiology and biology of pancreatic cancer among Iranian patients: an updated preliminary review. Advan. Trans. Med., 2022, 1(1)
[5]
Kristensen, L.S.; Hansen, T.B.; Venø, M.T.; Kjems, J. Circular RNAs in cancer: Opportunities and challenges in the field. Oncogene, 2018, 37(5), 555-565.
[http://dx.doi.org/10.1038/onc.2017.361] [PMID: 28991235]
[6]
Shao, F.; Cai, M.; Fan, F.F.; Huang, M.; Tao, Y.; Wang, C.; Meng, F.T.; Huang, Q. Overexpression of circRNA chr7:154954255-154998784+ in cancer-associated pancreatic stellate cells promotes the growth and metastasis of pancreatic cancer by targeting the miR-4459/KIAA0513 axis. Am. J. Transl. Res., 2020, 12(9), 5048-5063.
[PMID: 33042405]
[7]
Yang, F.; Liu, D.Y.; Guo, J.T.; Ge, N.; Zhu, P.; Liu, X.; Wang, S.; Wang, G.X.; Sun, S.Y. Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer. World J. Gastroenterol., 2017, 23(47), 8345-8354.
[http://dx.doi.org/10.3748/wjg.v23.i47.8345] [PMID: 29307994]
[8]
Qu, S.; Hao, X.; Song, W.; Niu, K.; Yang, X.; Zhang, X.; Shang, R.; Wang, Q.; Li, H.; Liu, Z. Circular RNA circRHOT1 is upregulated and promotes cell proliferation and invasion in pancreatic cancer. Epigenomics, 2019, 11(1), 53-63.
[http://dx.doi.org/10.2217/epi-2018-0051] [PMID: 30444423]
[9]
Chen, B.; Ji, F.; Wen, X.; Jin, Z. Circular RNA circ_ASAP2 promotes cell viability, migration, and invasion of gastric cancer cells by regulating the miR-770-5p/CDK6 axis. Int. J. Clin. Exp. Pathol., 2020, 13(11), 2806-2819.
[PMID: 33284890]
[10]
Jafarzadeh, A.; Paknahad, M.H.; Nemati, M.; Jafarzadeh, S.; Mahjoubin-Tehran, M.; Rajabi, A.; Shojaie, L.; Mirzaei, H. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target. Biomed. Pharmacother., 2022, 146, 112600.
[http://dx.doi.org/10.1016/j.biopha.2021.112600] [PMID: 34968919]
[11]
Wang, H.; Chen, S.H.; Kong, P.; Zhang, L.Y.; Zhang, L.L.; Zhang, N.Q.; Gu, H. Increased expression of miR-330-3p: A novel independent indicator of poor prognosis in human breast cancer. Eur. Rev. Med. Pharmacol. Sci., 2018, 22(6), 1726-1730.
[PMID: 29630118]
[12]
Shen, L.; Yi, S.; Huang, L.; Li, S.; Bai, F.; Lei, S.; Breitzig, M.; Czachor, A.; Sun, H.; Zheng, Q.; Wang, F. miR-330-3p Promotes lung cancer cells invasion, migration, and metastasis by directly targeting hSOD2b. Biotechnol. Appl. Biochem., 2019, 66(1), 21-32.
[http://dx.doi.org/10.1002/bab.1691] [PMID: 30192404]
[13]
Zhao, X.; Chen, G.Q.; Cao, G.M. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma. Eur. Rev. Med. Pharmacol. Sci., 2019, 23(16), 6888-6898.
[PMID: 31486488]
[14]
Xiong, X.; Shi, Q.; Yang, X.; Wang, W.; Tao, J. LINC00052 functions as a tumor suppressor through negatively modulating miR-330-3p in pancreatic cancer. J. Cell. Physiol., 2019, 234(9), 15619-15626.
[http://dx.doi.org/10.1002/jcp.28209] [PMID: 30712321]
[15]
Xia, L.; Song, M.; Sun, M.; Chen, W.; Yang, C. miR-486 Promotes Capan-2 pancreatic cancer cell proliferation by targeting phosphatase and tensin homolog deleted on chromosome 10 (PTEN). Front. Genet., 2019, 10, 541.
[http://dx.doi.org/10.3389/fgene.2019.00541] [PMID: 31258546]
[16]
Arocho, A.; Chen, B.; Ladanyi, M.; Pan, Q. Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn. Mol. Pathol., 2006, 15(1), 56-61.
[http://dx.doi.org/10.1097/00019606-200603000-00009] [PMID: 16531770]
[17]
Huang, S.; Yang, B.; Chen, B.J.; Bliim, N.; Ueberham, U.; Arendt, T.; Janitz, M. The emerging role of circular RNAs in transcriptome regulation. Genomics, 2017, 109(5-6), 401-407.
[http://dx.doi.org/10.1016/j.ygeno.2017.06.005] [PMID: 28655641]
[18]
Qi, X.; Zhang, D.H.; Wu, N.; Xiao, J.H.; Wang, X.; Ma, W. ceRNA in cancer: Possible functions and clinical implications. J. Med. Genet., 2015, 52(10), 710-718.
[http://dx.doi.org/10.1136/jmedgenet-2015-103334] [PMID: 26358722]
[19]
Abreu, F.B.; Liu, X.; Tsongalis, G.J. miRNA analysis in pancreatic cancer: The dartmouth experience. Clin. Chem. Lab. Med., 2017, 55(5), 755-762.
[http://dx.doi.org/10.1515/cclm-2017-0046] [PMID: 28343174]
[20]
Álvarez-Garcia, V.; Tawil, Y.; Wise, H.M.; Leslie, N.R. Mechanisms of PTEN loss in cancer: It’s all about diversity. Semin. Cancer Biol., 2019, 59, 66-79.
[http://dx.doi.org/10.1016/j.semcancer.2019.02.001] [PMID: 30738865]
[21]
Qian, X.; Li, X.; Shi, Z.; Xia, Y.; Cai, Q.; Xu, D.; Tan, L.; Du, L.; Zheng, Y.; Zhao, D.; Zhang, C.; Lorenzi, P.L.; You, Y.; Jiang, B.H.; Jiang, T.; Li, H.; Lu, Z. PTEN suppresses glycolysis by dephosphorylating and inhibiting autophosphorylated PGK1. Mol. Cell, 2019, 76(3), 516-527.e7.
[http://dx.doi.org/10.1016/j.molcel.2019.08.006] [PMID: 31492635]
[22]
Zhang, H.; Liu, A.; Feng, X.; Tian, L.; Bo, W.; Wang, H.; Hu, Y. miR-132 promotes the proliferation, invasion and migration of human pancreatic carcinoma by inhibition of the tumor suppressor gene PTEN. Prog. Biophys. Mol. Biol., 2019, 148, 65-72.
[http://dx.doi.org/10.1016/j.pbiomolbio.2017.09.019] [PMID: 28941804]
[23]
Zhang, G.F.; Zhong, J.M.; Lin, L.; Liu, Z.H. miR-19 enhances pancreatic cancer progression by targeting PTEN through PI3K/AKT signaling pathway. Eur. Rev. Med. Pharmacol. Sci., 2020, 24(3), 1098-1107.
[PMID: 32096172]

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy